Altered fractionation for non-small cell carcinoma of the lung. Rationale for the prospective trials of the Radiation Therapy Oncology Group.

5th Would Conference on Lung Cancer 6 Banham F, Soukop M, Burnett A, et al. Treatment of small cell carcinoma of lung with a late dosage intensification programme containing cyclophosphamide and mesna. Cancer Treat Rep 1983; 10:(suppl):73-77 7 Sculier JP, Klastersky J, Stryckmans P, et al. Late intensification in small cell lung cancer: a phase 1 study of high dose of cycbophosphamide and etoposide with autobogous bone marrow transplantation. ,J Clin Oncol 1985; 3:184-191 8 Smith IE, Evans BD, Harland SJ, et al. High-dose cyclophosphamide with autologous bone marrow rescue after conventional therapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol 1985; 14:120-24 9 Spitzer C, Farha P, Valdivieso M, et al. High dose intensification therapy with autologous bone marrow support for limited small cell bronchogenic carcinoma. J Clin Oncol 1986; 4:4-13 10 Humblet Y, Symann M, Bosly A, et al. Late intensification chemotherapy with autobogous bone marrow transplantation in selected small cell carcinoma of the lung: a randomized study. J Clin Oncol 1987; 5:1864-73 11 Souhamni RL, Finn C, Cregory W, et al, Very high dose cyclophosphamide as initial treatment for small cell carcinoma of the lung. J Clin Oncol 1985; 3:958-63 12 Wolf SN, Johnson DH, Hande KR, et al, High dose etoposide as single agent chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 1983; 67:957-58 13 Farha P, Spitzer C, Valdivieso M, et al. High dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 1983; 52:1351-55